|
|
|||||||||
|
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail. Summary Table. Rotavirus Vaccine for the Prevention of Rotavirus Gas Among Children Recommendations of the Advisory Committee on Immunization Practices (ACIP)Summary Table. Recommendations and Quality of Evidence Rotavirus Vaccine Recommendations
Advisory Committee on Immunization Practices, 1999
(Table_1) Summary Table. Recommendations and Quality of Evidence Rotavirus Vaccine Recommendations Advisory Committee on Immunization Practices, 1999 ===================================================================================================================================== Level of Strength of Recommendations Evidence* Evidence+ ------------------------------------------------------------------------------------------------------------------------------------- Provide routine vaccination at 2,4,and 6 months of age. I A Administer to breastfed infants. I A Administer with DTP (or DTaP),Hib vaccine,OPV,IPV,and hepatitis B vaccine. I A Administer to infants with mild illnesses. I B Not recommended for Infants with known or suspected immunodeficiency III C Infants with hypersensitivity to vaccine components III B Infants with acute gastrointestinal disease III C Infants with moderate to severe febrile illness III C Precautions and special situations Premature infants (<37 weeks gestational age) III C Infants living in households with immunocompromised persons III C Timing of administration of antibody-containing blood products and rotavirus vaccination III C Infants with preexisting chronic gastrointestinal illnesses III C Vaccine that is regurgitated III C Late or incomplete immunization III C Children hospitalized after vaccination III C ------------------------------------------------------------------------------------------------------------------------------------- * Level of Evidence I Evidence from randomized, controlled trials II Evidence from other epidemiologic studies III Opinions of authorities + Strength of Evidence A Good evidence to support recommendation B Fair evidence to support recommendation C Insufficient evidence ===================================================================================================================================== Return to top. Disclaimer All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices. **Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.Page converted: 03/18/99 |
|||||||||
This page last reviewed 5/2/01
|